Tampa, FL -- (SBWIRE) -- 04/24/2019 -- Los Angeles Lakers forward Brandon Ingram missed the rest of what had been a breakout season after being diagnosed with a deep vein thrombosis in his right arm.

The episode shows that blood clots can happen to anyone, not just the elderly or unwell.

That is the take-home message for Greg Grambor. He is president of Vascular PRN, a national distributor of pneumatic compression therapy devices for the prevention of blood clots.

"This is a professional athlete in his prime, under the care of world-class doctors, and he had a deep vein thrombosis," Grambor said. "We all need to be aware of the risk."

Ingram's diagnosis came after he reported pain in his shoulder. He successfully underwent surgery to remove the clot and is expected to make a full recovery, but he will not be cleared to return to the court before the end of the season.

Ingram is not the first to be sidelined by a blood clot. Miami Heat superstar Chris Bosh experienced at least two clots which, with related complications, ended his career early.

Grambor foresees an uptick in interest in clot prevention in the sports world.

"You can't prevent 100 percent of clots, but with modern compression therapy and active awareness, the harm associated with clots can be minimized."

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Tampa, FL -- (SBWIRE) -- 03/27/2019 -- Pneumatic compression therapy has achieved a key breakthrough with the portable PlasmaFlow system, a battery-operated device for DVT prevention and enhanced circulation.

"The PlasmaFlow is one of our most popular products," said Greg Grambor, president of Vascular PRN, a leading national distributor of medical devices. "It truly is a revolutionary product."

Sequential pneumatic compression is a key therapy for post-surgical patients and those with limited mobility.

Until recently, pneumatic compression devices were usually bulky, heavy, expensive and difficult to use.

The PlasmaFlow is a revolutionary product that solves these problems and more.
- The PlasmaFlow is battery-operated and can be used on the go in wheelchairs, cars and airplanes.

- Miniaturized pumps and improved battery technology mean the PlasmaFlow is compact and lightweight — not to mention quiet.

- Simplified controls make the PlasmaFlow easy for patients to understand and use.

"The best part of PlasmaFlow for outpatient use is the high rates of patient adherence," Grambor said. "The device is simple, portable and comfortable. This means resistance from patients is very low, which doctors know is a key factor in patient outcomes."

The battery lasts up to 10 hours on a charge — plenty of time for the longest trips away from a power source. When plugged in, the PlasmaFlow's batteries charge even when the device is in use. LCD screens indicate pressure and battery levels at a glance.

To learn more about PlasmaFlow and other cutting-edge medical devices, call VascularPRN today.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Tampa, FL -- (SBWIRE) -- 02/27/2019 -- For many patients with critical limb ischemia (CLI), surgical interventions are longstanding treatment options with generally good results.

In cases where such treatment is not possible, sequential pneumatic compression can mean the difference between salvaging and amputating the affected limb.

Greg Grambor is president of Vascular PRN, a leading national distributor of pneumatic compression therapy devices including arterial compression systems for limb salvage.

"The benefits of compression therapy are enormous," Grambor said. "Restored blood flow, reduced pain, and often limb salvage. It's also inexpensive and completely non-invasive."

Grambor said these factors all contribute to a high rate of patient compliance.

"Patients love pneumatic compression. It can be performed at home and on the go, and it's painless," Grambor said.

Ischemia is a condition marked by inadequate blood flow — and therefore oxygenation — to a part of the body. Advanced cases can result in CLI, marked by increasing pain and potential loss of tissue and limbs.

Primary surgical treatments for ischemia include vascular bypass (reconnecting blood vessels to redirect blood flow) and angioplasty (forced expansion of a blood vessel using a balloon catheter). These procedures are two forms of revascularization.

For various reasons, such surgical revascularization is not possible in some cases. For these vulnerable patients, the unfortunate last resort is often amputation of the affected limb.

Many, however, can and do benefit from sequential pneumatic compression. This non-invasive and painless treatment enhances blood flow and oxygenation, relieves pain, and can save limbs that might otherwise require amputation.

Studies verifying these findings have led to an upswing in the use of the treatment, Grambor said.

"More and more hospitals and nursing homes are employing pneumatic compression therapy every day."

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Tampa, FL -- (SBWIRE) -- 02/11/2019 -- Non-invasive and affordable treatment with high compliance rates is available for patients with intermittent claudication.

Intermittent claudication is muscle pain during mild exertion such as walking which subsides when at rest. It most commonly occurs in the calf muscle and is associated with early-stage peripheral artery disease. Its cause is insufficient flow of oxygenated blood to the muscles.

Greg Grambor, president of Vascular PRN, is on a mission to spread awareness of pneumatic compression therapy. Sequential and intermittent therapy devices are designed to stimulate and assist the natural blood flow and oxygenation mechanisms in the body's extremities.

Vascular PRN specializes in the distribution of this equipment to hospitals, nursing homes and patients.

"A variety of conditions are treatable with pneumatic compression, either as a substitute for or complement to riskier and more invasive therapies," Grambor said. "The PlasmaFlow is a great choice in particular for intermittent claudication. It's portable and lightweight, and its batteries last up to 10 hours on a charge"

Studies at the Mayo Clinic and other hospitals have shown decreased pain and increased mobility in patients with intermittent claudication who are treated with pneumatic compression therapy.

Grambor said that intermittent claudication is a fitting application for this treatment because it is often an early-stage symptom present when the underlying conditions are reversible. If the symptomatic pain is treated, and the ability to exercise is increased, the body's circulatory systems can return to normal functioning.

"Pneumatic compression therapy is tremendously important for post-surgical patients and those with very limited mobility. But doctors and patients should also be aware of its ability to treat more common and less severe conditions and contribute to overall quality of life."

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Tampa, FL -- (SBWIRE) -- 09/26/2018 -- Researchers at Royal Perth Hospital in Australia have found that children as young as 12 have suffered deep vein thrombosis (DVT) following extended periods of playing video games.

Children can become so completely absorbed in sedentary activities such as video games that they remain nearly motionless for extended periods of time. This leads to the dangerous blood clots, according to the recent study.

"Adults need to take heed of what this study means for them," said Greg Grambor.

Grambor is the founder of Vascular PRN, a national distributor of pneumatic compression devices for the prevention of DVT.

"It's practically unheard of for children this young to experience deep vein thrombosis," Grambor went on. "But modern technology captivates them and keeps them motionless. It's not natural."

The take-home message for grown-ups, according to Grambor, is that the risks across all age groups are underestimated.

"It's not just kids, and it's not just video games. Many adults are sedentary at computers, at desks, in airplanes and in cars in the course of doing our jobs. And the elderly and retired experience declining mobility in their later years. No one is immune to DVT risk factors," Grambor said.

Most child DVT cases documented in the study involved clots in the legs, such as a 12-year-old boy who played games for four hours in a kneeling position. Another boy, however, experienced a clot in his arm after several hours of gaming while lying on his back.

The DVT was associated not only with stillness, but also dehydration. Researchers said the children ignored their thirst because they were so absorbed.

Controlling DVT risk is not a matter of vigorous exercise or high levels of activity, Grambor explained.

"Even athletes get blood clots. Avoiding DVT is about awareness and specific prevention. Simply standing up for a few minutes can cut risks dramatically. Avoid becoming entranced by the screens you look at — get up and take a break."

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Tampa, FL -- (SBWIRE) -- 08/13/2018 -- The family of actor Bill Paxton has filed a wrongful death lawsuit against the surgeon and hospital that treated him in the days leading up to his death.

Paxton died of a stroke 11 days after undergoing surgery to replace a heart valve and correct an aneurysm. According to a report by the University of Southern California, the stroke was likely caused by a blood clot that formed after surgery and got lodged in the brain.

Increasingly, hospitals are employing reliable and non-invasive pneumatic compression therapy devices for the prevention of blood clots following surgery. Greg Grambor is the president of Vascular PRN, a national distributor of such equipment.

"We don't know whether pneumatic compression was advisable or prescribed in Paxton's specific case," Grambor said. "But surgery can cause dangerous clots both directly at the part of the body operated on, and indirectly via reduced mobility — usually in the legs. Clot prevention is a primary post-surgical concern, and often, pneumatic compression therapy plays a key role."

Paxton's family is suing world-famous Cedars-Sinai hospital in Los Angeles, as well as Paxton's surgeon. They allege that the risks of the surgery were not adequately explained and the surgeon was inexperienced in the procedure. Further, the complaint alleges that complications from the surgery were not dealt with in a timely manner.

Just a week prior to the surgery, Paxton revealed in an interview with Marc Maron that he had suffered damage to his heart after contracting rheumatic fever as a child.

Grambor encourages surgery patients to speak with their doctors about effective clot prevention including non-invasive options.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Tampa, FL -- (SBWIRE) -- 08/03/2018 -- Prolonged sitting is shown to increase the likelihood of a host of risk factors including blood clots and poor heart function.

As an ever-increasing portion of the workforce is employed in desk jobs and those involving extensive computer work, research has begun to emerge showing just how unhealthy long periods of sitting and inactivity can be.

Greg Grambor knows blood clots. He is the president of Vascular PRN, a national distributor of pneumatic compression therapy devices for preventing clots.

"So many people sit all day, every day at their jobs," Grambor said. "This can cause blood clots to form in the legs, even for healthy people without other risk factors. Combined with the gradual degradation of heart function that comes with a sedentary lifestyle, this can spell disaster. The pneumatic compression devices available from Vascular PRN are a non-invasive way to help prevent clots from forming."

Among the research sounding the alarm is a 2017 Columbia University study of nearly 8,000 adults 45 and older. It found those who sat for greater lengths during the day ran as much as twice the risk of death as those who sat less. And a 2016 Cambridge University study showed that one in six deaths in the United Kingdom were caused by conditions linked to office lifestyles, including heart disease and stroke.

Grambor pointed out that even for those unable to get up and move regularly, the risk of clots, at least, may be mitigated.

"Exercise and activity are surely the most effective way to reduce risk," he said. "But that is not an option for everyone at all times. When physical activity is limited, pneumatic compression therapy devices can be a key part of a comprehensive health strategy."

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Tampa, FL -- (SBWIRE) -- 07/23/2018 -- Pregnant women run an increased risk of deep vein thrombosis (DVT) and other potentially fatal blood clots. Pregnancy itself, combined with prolonged bed rest or sitting — common in the latter months — tends to increase the risk of clots that can cause heart attack, stroke and pulmonary embolism.

Many pregnant women are prescribed blood thinners to prevent clotting, but these can cause complications and must be ceased before labor. A less invasive option is pneumatic compression.

Greg Grambor is president of Vascular PRN, a national distributor of pneumatic compression therapy equipment.

"Pneumatic compression in some cases can reduce or eliminate the need for dangerous blood thinners," Grambor said. "It's an option all pregnant women and their doctors should take into consideration."

The risk of clots during pregnancy recently received some high-profile attention with the release of HBO's series "Being Selena" about star tennis player Serena Williams. In it, Williams discusses how her delivery earlier this year could have ended in tragedy.

Williams wanted to avoid a C-section due to her known high risk of blood clots. In fact, she had already suffered a pulmonary embolism in 2011. However, complications during Williams' delivery made an emergency C-section necessary.

Unfortunately, Williams suffered another pulmonary embolism in the weeks following the C-section. She describes waking up unable to take a deep breath. The embolism was found and treated, as were subsequent clots discovered in her legs. In the end, Williams counts herself lucky to be alive.

"Serena's story brings some much-needed attention to the risks pregnant women face, which are significant but highly manageable with modern tools," Grambor added.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Tampa, FL -- (SBWIRE) -- 06/22/2018 -- A new market research report predicts the global market for pneumatic compression therapy devices, already a strong-performing segment of the health care industry, will continue to grow through 2025.

Vascular PRN of Tampa, Florida, a leading national distributor of pneumatic compression products, is poised to grow along with this market. The company's president, Greg Grambor, said the impressive forecast comes as no surprise.

"We're seeing more hospitals and nursing homes come to rely on pneumatic compression as a first-line defense against deep vein thrombosis (DVT), lymphedema and other ailments," Grambor said.

The report, published by Persistence Market Research, predicts the global market will grow to $670 million in 2025, with North America leading in revenue generation. High prevalence of varicose vein disease and deep vein thrombosis are key factors in the forecast, as well as increasing support for reimbursement of pneumatic compression costs by insurers.

Other key growth factors include increasing patient awareness and home care equipment. According to Greg Grambor, when patients learn about pneumatic compression, they tend to inquire about it and request it from their doctors.

"The therapy is very non-invasive, comfortable and easy to follow," Grambor said, "and modern devices are easily used in the home and even on the go with portable models. High patient compliance and satisfaction is one of the best parts of this health care success story."

Based on distribution channels, the compression therapy market is divided into three segments: Hospitals, Clinics and E-Commerce. Market research indicates the hospital segment is expected to be the largest in terms of revenue, followed by clinics and then e-commerce.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Tampa, FL -- (SBWIRE) -- 04/20/2018 -- A new study ties the apparently benign condition to far more serious health risks.

Taiwanese researchers found that among those with varicose veins, higher rates of deep vein thrombosis (DVT), pulmonary embolism (PE) and peripheral artery disease (PAD) were present.

Greg Grambor is president of Vascular PRN, a national distributor of intermittent pneumatic compression devices widely used for prevention of DVT and other conditions.

"Many people with varicose veins put them out of their mind because they may find the condition embarrassing, and it is not thought to be directly harmful," Grambor said. "This research might show that these people should take a more proactive approach."

The study analyzed data from Taiwan's National Health Insurance program and compared 212,984 adult patients with varicose veins with an equal number of adults without the condition. The two groups had similar mean ages and male-female distributions.

The study showed a dramatically higher incidence of DVT among those with varicose veins, at 6.55 per 1000 person-years compared with 1.23 for those without — a rate more than five times higher.

Less dramatic — but still significant — differences were found in rates of PE and PAD. The incidence rates were 0.48 vs. 0.28 for PE and 10.73 vs. 6.22 for PAD per 1000 person years for those with and without varicose veins, respectively.

The results showed no significant differences on the basis of sex or age.

It is important to note that the study demonstrates a correlation between varicose veins and these hazardous conditions — not causation. In other words, while these conditions appear to be associated with varicose veins, it is not clear whether they are caused by them.

Grambor advises a cautious approach undertaken with a doctor's advice.

"I recommend anyone with varicose veins or other DVT risk factors speak with their doctor about the non-invasive DVT prevention strategies available," Grambor said.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Tampa, FL -- (SBWIRE) -- 03/21/2018 -- Shoppers for home medical equipment and supplies are discovering Braces, Bandages & Beyond, a new online health care store from Vascular PRN, found at http://www.BracesBandagesandBeyond.com.

VascularPRN is a leading national distributor of intermittent and sequential pneumatic compression devices (SCDs) for the prevention of dangerous blood clots. Hospitals and nursing homes have long depended on VascularPRN.com for the compression therapy equipment they prescribe.

Now, Greg Grambor, president of Vascular PRN, turns his attention to patients with diverse non-prescription health care needs who want the convenience of shopping online. Some prescription items are also available on the site.

"I saw an unmet need in the marketplace and I wanted to fill that," Grambor said. "Braces, Bandages, & Beyond is my attempt to bring great selection, great service, and low prices together in a modern online store."

Braces, Bandages & Beyond carries a wide array of high-quality health care items. Customers are sure to find what they are looking for and save the trouble of calling or driving to store after store.

At BB&B, shoppers will find neck braces, back braces, leg braces, and arm slings. Customers can buy incontinence and erectile dysfunction aids in the privacy of their own homes. CPAP machines, wheelchairs, walking aids, a wide variety of compression stockings, and many more products are available.

"Consumers are more online-savvy all the time," Grambor said. "They want an easy-to-use online store for non-prescription devices and supplies, and we deliver this in spades."

Visit http://www.BracesBandagesandBeyond.com or call 888-817-5678 today.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Tampa, FL -- (SBWIRE) -- 01/30/2018 -- Turkish researchers found that intermittent pneumatic compression (IPC) significantly reduced knee swelling in patients with knee osteoarthritis (OA).

The study's authors noted IPC's common use in treating lymphedema and venous leg ulcers, but found a lack of literature on the therapy's use in musculoskeletal injuries, particularly in OA patients with knee swelling.

Greg Grambor, president of Vascular PRN, said the study was the latest in a long series of positive research on IPC. His company is a national distributor of pneumatic compression devices to hospitals, nursing homes and patients.

"The research is piling up now, providing scientific validation of what doctors have long suspected based on their own experience: intermittent pneumatic compression has a range of positive effects for patients with many different conditions," Grambor said.

Researchers divided test subjects into two groups. Both the control group and experimental group received electrical nerve stimulation, ultrasound and exercise. The control group also received cold packs, a standard therapy for knee swelling, while the experimental group received IPC. A significant difference in knee swelling in favor of the IPC group was found.

Intermittent pneumatic therapy works by rhythmically compressing the limbs, stimulating blood flow and decreasing fluid retention. Research shows generally high rates of patient compliance and low risk of complications.

The researchers noted that both groups showed significant improvement in secondary symptoms, including range of motion, strength and pain.

"As awareness of this non-invasive, drug-free, affordable therapy increases, I look forward to helping doctors and patients achieve their goals," Grambor said.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Tampa, FL -- (SBWIRE) -- 12/28/2017 -- A Chicago jury awarded $3 million to the family of a man who died of a blood clot 50 days after undergoing leg surgery.

The lawsuit accused doctors at Elmhurst Hospital of failing to properly prevent, diagnose, and treat Edward Smolinski when he presented symptoms of a pulmonary embolism.

Greg Grambor said post-surgical blood clots, while common, are highly preventable. Grambor is president of Vascular PRN, a national distributor of pneumatic compression therapy devices for the prevention of blood clots and other ailments.

"Recent surgery is a leading risk factor for fatal blood clots," Grambor said. "Pneumatic compression is a highly effective preventative therapy with high patient compliance rates. It's not clear whether the therapy was employed in this case, but doctors are increasingly turning to it to prevent exactly this sort of death."

Smolinski became a patient at Elmhurst Hospital when he ruptured a tendon in his leg in the summer of 2011. After surgery, he was sent home the same day. Six weeks later, during physical therapy at Elmhurst, he complained of shortness of breath and chest pain, and later experienced leg swelling. Eight days later, he was found dead in his home.

The family settled their separate case against a doctor who treated Smolinski for $1.5 million.

Smolinski, 52, was the father of two high school age children.

"My hope is that intermittent pneumatic compression, as part of a comprehensive clot prevention strategy, can help prevent needless deaths and make surgical recovery far less dangerous," Grambor said.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Tampa, FL -- (SBWIRE) -- 10/17/2017 -- A systematic review of eight studies shows that pneumatic compression therapy likely has a number of positive effects.

Researchers at Danish hospitals reviewed studies of patients undergoing ankle surgery and receiving either intermittent pneumatic compression, a compression stocking, and/or a compression bandage. They found pneumatic compression has a positive effect on edema and likely also has a positive effect on pain and ankle joint mobility.

"This should help get the word out about this highly advantageous therapy," said Greg Grambor. He is president of Vascular PRN, a national distributor of pneumatic compression therapy equipment.

"I've seen it myself time and time again, but of course, it's always good to see formal research validate what so many doctors already know."

Pneumatic compression, distinct from static compression offered by bandages and stockings, involves the rhythmic increase and reduction of pressure on the affected limb, enhancing blood flow, preventing blood clots and reducing fluid retention.

The therapy is non-invasive and, while often used in conjunction with prescription blood thinners, can reduce the need for them, yielding decreased potential for complications.

Seven of the eight studies reviewed showed a significant reduction of edema for patients on pneumatic compression therapy.

"Combine these proven benefits of pneumatic compression with its low cost and low risk, as well as its high rate of patient adherence, and it really is an easy choice in post-surgical treatment," Grambor said.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Tampa, FL -- (SBWIRE) -- 09/21/2017 -- A late mother's family recently settled its lawsuits against multiple parties who allegedly failed to properly diagnose and treat blood clots in her legs.

On September 21, 2011, Anna Brown went to two St. Louis, Missouri-area hospitals complaining of severe leg pain. Doctors at both hospitals failed to diagnose her deep vein thrombosis (DVT) and discharged her. When she refused to leave the second hospital, police charged her with trespassing and took her to jail, where she later died.

"This story is utterly heartbreaking," said Greg Grambor. He is president of Vascular PRN, a national distributor of pneumatic compression equipment for the prevention of DVT. "The doctors should have recognized her blood clot and treated it."

Brown was a homeless mother who had lost custody of her two children. Days after spraining her ankle, she had such severe pain in her legs that she could not stand. Brown first visited a pediatric hospital, where doctors had an ambulance take her to St. Mary's Health Center in Richmond Heights. There, ultrasound tests on both her legs were negative for blood clots, according to doctors.

After being discharged, Brown refused to leave. Police arrested her and charged her with trespassing after doctors deemed her "fit for confinement" – that is, healthy enough to go to jail. Police noted "suspected drug use" in the arrest report.

Surveillance tapes showed Brown asked for and was denied a wheelchair, according to the St. Louis Post-Dispatch. Approximately one hour after being carried into her cell, the tapes show Brown stopped moving. Shortly thereafter, workers discovered her unresponsive, attempted CPR, and rushed her back to St. Mary's, but Brown was soon dead from a pulmonary embolism.

The incident led to public protests outside St. Mary's as well as a prosecutorial review, which resulted in no charges filed. Brown's family filed a civil lawsuit against the jail, both hospitals, and the doctors involved. The case number was 1222-CC10603, filed November 20, 2012 in the 22nd Circuit Court of Missouri.

After a years-long wrongful death lawsuit battle, all defendants settled jointly with the plaintiffs. All the conditions were confidential except the amount paid in public funds of the city of Richmond Heights: $568,750.

Grambor said DVT is common after suffering an ankle sprain. Brown had already visited two other hospitals in previous weeks after spraining her ankle.

"Comprehensive clot prevention following her injury, including pneumatic compression therapy, could have saved Anna Brown's life," Grambor said.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Tampa, FL -- (SBWIRE) -- 06/28/2017 -- Even elite athletes are not invulnerable to blood clots.

This is the message Greg Grambor wants people to understand. He is the president of Vascular PRN, a Tampa, Florida-based national distributor of pneumatic compression devices for the prevention of deep vein thrombosis (DVT) and other conditions.

"It's not just the elderly and the surgical patients in the hospitals and nursing homes who are at risk," Grambor said. He was recently gratified to see a story in a popular magazine about a healthy athlete who had a brush with a dangerous clot.

Writing in Reader's Digest, Jen Babakhan tells the story of Mary Dillhoff, who is not only a marathon runner but also a surgeon. She is in such good shape that she ran a full marathon while 26 weeks pregnant.

Shortly thereafter, however, Dillhoff began having significant shortness of breath. Despite her medical training, she erroneously attributed it to her pregnancy. Soon, though, after driving in her car for several hours, her lower left leg was swollen and discolored. She then knew she had a deep vein thrombosis and that her earlier shortness of breath had likely been due to a pulmonary embolism that, while minor, could have been fatal.

Dr. Dillhoff's subsequent treatment was lengthy and nerve-wracking, but she was able to safely deliver her baby and then receive surgical treatment of the blood clot.

The risk of deep vein thrombosis is some four to five times greater in pregnant women.

"Here we have a medical professional with elevated risk factors who failed to recognize clear symptoms of DVT and pulmonary embolism in herself," Grambor said. "And not only that, but she was in extraordinary health in general. It just goes to show you that it can happen to anyone, and we all need to understand the risks."

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Tampa, FL -- (SBWIRE) -- 05/16/2017 -- A recent market research report forecasts robust growth in demand for compression therapy medical equipment.

The continuing market growth for compression therapy will come as the result of a similar increase in the pace of surgeries, market researchers found. The prediction comes as no surprise to Greg Grambor. As president of Vascular PRN, a leading distributor of pneumatic compression therapy devices, he sees demand for the technology rising steadily.

"As the rate of surgeries picks up, many of those procedures are very well-suited to compression therapy," Grambor said. "More doctors, hospitals, and nursing homes are discovering the benefits of compression therapy every day. They can see for themselves the cost savings, the excellent patient compliance and the post-surgical recovery."

The report, titled "Global Compression Therapy Market 2017-2021," finds a recent uptrend in compression therapy following surgery for the prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE). The devices are also used during lengthy laparoscopic surgery in order to prevent venous blood return.

Researchers also noted that pneumatic sequential compression therapy generates rapid results in just one to two hours per day, while static compression therapy can take up to 48 hours to show a similar result.

Some of the highest growth rates in compression therapy are forecast for the Eastern Hemisphere. Researchers predict robust demand in the Asia-Pacific market due to high inclination toward medical innovation as well as a rise in chronic ailments in the region.

"A move away from dangerous blood thinners and toward non-invasive compression therapy is to be expected in high-growth, innovative markets," Grambor added.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Tampa, FL -- (SBWIRE) -- 03/24/2017 -- March is national Blood Clot Awareness Month in the United States, and the president of one national distributor of medical devices is always glad for the chance to discuss the dangers of clots.

"It's important for people to understand that blood clots can affect anyone," said Greg Grambor president of Vascular PRN, a leading distributor of pneumatic compression therapy devices for the prevention of deep vein thrombosis. "You don't have to be elderly or unhealthy to get a blood clot," Grambor went on. "You don't have to be bedridden or have had a recent surgery. There are so many causes and so many factors."

The creation of Blood Clot Awareness Month was spearheaded by two U.S. Representatives, Lois Capps (D-CA) and Cathy McMorris Rodgers (R-WA). Each of them lost a loved one to a type of blood clot known as a pulmonary embolism.

"Hospitals and nursing homes are incorporating pneumatic compression therapy into their patient care in increasing numbers," Grambor said. "That's because in addition to being very non-invasive and easy for the patient to accept, it's also effective and low-cost. But it's not just institutions that use compression therapy. With a doctor's prescription, people are using the devices in their homes and even as they travel, with the help of our portable models."

About The National Blood Clot Alliance
The National Blood Clot Alliance (NBCA), a non-profit organization that is devoted to advancing the prevention, diagnosis and treatment of life-threatening blood clots like, pulmonary embolism or deep vein thrombosis. The NBCA will be posting information regarding Blood Clot Awareness Month to their website throughout the month. The posts will cover topics including warning signs and prevention, stories of people affected by blood clots, and how people can help spread awareness and make a difference.

"I recommend anyone who is unfamiliar with the warning signs and risk factors of blood clots [to] educate themselves this month," Grambor said. "Not just for themselves, but for the sake of their loved ones as well."

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Tampa, FL -- (SBWIRE) -- 02/01/2017 -- At least one high-profile celebrity death in 2016 was caused by a blood clot.

A Los Angeles County medical examiner's report, recently made public, says that Garry Shandling's March, 2016 death was caused by pulmonary thrombosis — a blood clot that became lodged in his lungs.

The comedian's death, while tragic, might nevertheless serve to educate people on the dangers of blood clots, says Greg Grambor. He is president of Vascular PRN, a leading national distributor of pneumatic compression therapy equipment.

"Reports say Shandling complained of shortness of breath and leg pain the day before his death," Grambor said. "These are classic warning signs of pulmonary thrombosis, or pulmonary embolism. It's sad to say, but if he had recognized those signs and gone to a hospital, he would very likely be alive today."

The medical examiner's report stated that blood clots had formed in Shandling's legs, a condition called deep vein thrombosis. It also said that he had not been feeling well during an earlier trip to Hawaii. Long plane rides are a common risk factor for deep vein thrombosis.

People most at risk of a blood clot, include the elderly, those who fly frequently and those with a family history of blood clots. Grambor suggests that those who are at risk speak with their doctors about preventing thrombosis and embolisms.

"Doctor-prescribed pneumatic compression therapy can be performed in-home at the patient's convenience, or even during car trips and flights with portable devices," Grambor said. "It's a very affordable and non-invasive form of therapy."

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Tampa, FL -- (SBWIRE) -- 12/01/2016 -- New penalties took effect last month for hospitals with higher than expected rates of readmissions among Medicare patients.

The penalties were enacted under the Affordable Care Act and reduce the amount those hospitals are reimbursed for each Medicare patient for the fiscal year running October 1, 2016 through September 30, 2017.

Greg Grambor thinks about hospital readmissions often. He is the president of Vascular PRN, a national distributor of pneumatic compression therapy equipment for the prevention and treatment of deep vein thrombosis and other conditions. Grambor says pneumatic compression therapy works well for treatment in the home because it is easy to use and non-invasive.

"When patients follow their doctor's instructions carefully after release, they tend not to be readmitted to the hospital," Grambor said. "But many follow up treatments are burdensome. They often take place at medical facilities, requiring taking time out of your day, or they can be painful or high-effort."

Pneumatic compression therapy is different, according to Grambor.

"Patients administer the treatment themselves, in their own home. Battery-powered devices even allow treatment on the go. The process is easy and painless and does not require your attention," Grambor said. "Once you start it up, you're free to do anything you would normally do in a seated or reclined position."

National readmission rates have decreased since the Hospital Readmissions Reduction Program, which codifies the penalties, began in 2012. Hospitals are measured against benchmarks for Medicare patients who undergo certain procedures, including several surgeries. Compression therapy is an increasingly common treatment following any major surgery, which directly and indirectly contributes to blood clots.

"Word is getting out to hospitals that compression therapy is a great way to control costs and keep readmissions low," Grambor said.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Tampa, FL -- (SBWIRE) -- 10/17/2016 -- A new scientific study draws a correlation between blood clot deaths and watching television.

Researchers in Japan found that those who spend five or more hours per day watching television faced twice the risk of a fatal blood clot in the lungs than those who watched half as much.

Greg Grambor is not surprised. Grambor is president of Vascular PRN, a leading distributor of pneumatic compression devices for the prevention of pulmonary embolism, blood clots and deep vein thrombosis.

"It comes down to a lack of physical activity," Grambor said. "It isn't the television causing the blood clots; it's the extended periods of sitting instead of standing and moving around. That's why post-surgical and otherwise immobile patients are monitored so closely for clotting."

Grambor explained that as people sit in front of a TV or at a computer, dangerous blood clots can form, especially in the deep veins of the legs. When these clots dislodge, they can travel to the heart, brain or lungs, causing heart attack, stroke or pulmonary embolism.

Researchers also collected data on the subjects' weight, diabetic status, smoking habits and blood pressure. Even after correcting for these well-understood signals of blood clot risk, they found that extensive TV watching served as a further indicator of increased risk.

Previous studies have linked blood clots with other activities done while sitting for extended periods, such as riding in airplanes and cars. The U.S. sees more than 200,000 cases of pulmonary embolism per year.

Grambor pointed out that risk abatement for blood clots is a relatively straightforward matter.

"Sequential pneumatic compression is an affordable, non-invasive treatment available with a doctor's prescription. Many hospitals and nursing homes rely on these devices daily," he said. "And everyone can lower their risk simply by standing up and getting their blood flowing in their legs at least every couple of hours."

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Tampa, FL -- (SBWIRE) -- 08/15/2016 -- The use of pneumatic compression devices is associated with improved health and reduced cost of care in lymphedema patients, according to a recent study.

Dr. Pinar Karaca-Mandic, PhD, conducted a retrospective analysis of the health records of 718 lymphedema patients spanning 12 months before and after the use of pneumatic compression therapy. The study was published online in JAMA Dermatology.

Greg Grambor was pleased to see that the study used extensive real-world data in its analysis. Grambor is president of Vascular PRN, a distributor of pneumatic compression therapy devices.

"The doctors at the hospitals and nursing homes I work with are big believers in compression therapy," Grambor said. "But the fact is, hard scientific data on the efficacy of these devices is still somewhat lacking. I'm always glad to see studies like this, which will help bring this valuable and cost-effective therapy to more patients."

The study sample consisted of 374 patients whose lymphedema was cancer related and 344 non-cancer patients. In both groups, pneumatic compression therapy was associated with significant reductions in the rate of cellulitis infections and the cost of outpatient care. Cellulitis infection rates were found to have decreased in the cancer and noncancer groups by 79% and 75%, respectively. Outpatient costs, excluding equipment costs, decreased by 37% and 36% for the two groups.

"These numbers represent huge decreases in cost, complication, and patient discomfort," Grambor added.

Grambor also echoed researchers' calls for randomized, controlled trials, as well as the development of specific dosage recommendations for duration and pressure.

"Any formal study of this therapy is encouraging, but formal, randomized trials and dosage guidelines are what we need to really bring pneumatic compression therapy into the mainstream," Grambor said.

www.vascularprn.com

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Tampa, FL -- (SBWIRE) -- 07/15/2016 -- The market for compression therapy is forecast to grow rapidly over the next several years.

A recent report by Transparency Market Research forecasts strong growth in compression therapy through 2023. The report predicts a compounded annual growth rate of 5.2 percent for the period. The global market was valued at U.S. $2.5 billion in 2015 and is projected to grow to U.S. $4.0 billion by 2023.

The market for compression therapy may be segmented by technology, with dynamic compression therapy leading the projected growth as compared with static compression therapy. Similarly, when differentiating by product type, compression pumps are expected to see higher uptake compared to compression stockings, tapes and bandages.

According to the report, dynamic compression therapy offers distinct advantages over static compression, including less frequent bandage changes and highly effective treatment.

This forecast comes as no surprise to Greg Grambor. He is president of Vascular PRN, a national distributor of pneumatic compression therapy devices.

"As doctors learn about the safety and efficacy of dynamic compression, they are coming to rely on them to treat lymphedema and venous insufficiency, as well as to prevent deep vein thrombosis," Grambor said. "We're seeing more and more demand from hospitals and nursing homes, which see pneumatic compression as a key tool in keeping immobilized and sedentary patients healthy."

The report cites a rise in obesity as a key factor behind the growing demand for compression therapy, with obesity and deep vein thrombosis being closely related.

One restraining factor in the growth of compression therapy is a lack of favorable reimbursement policies among insurers, the report says.

"Insurers are a bit slow on the uptake," said Grambor, "but I'm confident that as doctors and patients increasingly demand dynamic compression therapy, they will see the necessity of accommodating this lifesaving technology," said Grambor.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Tampa, FL -- (SBWIRE) -- 03/17/2016 -- Lawsuits are piling up against the manufacturers of a popular blood thinning drug.

Since arriving on the market in 2011, Xarelto has been prescribed to millions of Americans for the prevention of stroke and embolism. But thousands of lawsuits against Bayer and Janssen Pharmaceuticals, a subsidiary of Johnson and Johnson, allege Xarelto puts patients at significant risk of uncontrollable bleeding. Some also accuse the companies of misleading marketing practices.

Greg Grambor is watching these developments with great interest. He is the president of Vascular PRN, a company that distributes pneumatic compression devices that offer an alternative method of blood clot prevention.

"Xarelto quickly became a top-selling drug when it received FDA approval in 2011," Grambor said. "Doctors were glad to finally have an alternative to warfarin, which itself had significant downsides. Now it appears Xarelto may not be much better."

Xarelto has partially supplanted warfarin, a 60-year-old blood thinner that requires very careful patient monitoring to achieve optimal dosage.

Grambor hopes the controversy surrounding Xarelto will lead doctors to take another look at therapies with less risk of complication, including compression therapy.

"In cases where embolism prevention is the primary concern, pneumatic compression is a terrific alternative or supplemental therapy to warfarin and Xarelto," Grambor said. "It uses alternating compression to enhance blood flow and prevent clotting in the limbs of immobilized patients, such as those recovering from surgery, or sedentary patients such as those in nursing homes."

The clinical trials that led to FDA approval of Xarelto have also come under scrutiny. A device used in the tests to measure blood thinness has since been recalled by its manufacturer for giving falsely low readings, which may have led to erroneous comparisons between warfarin and Xarelto.

"It's a complicated and unfortunate mess for doctors and patients," Grambor said. "I encourage doctors who are skeptical of these drugs to look into pneumatic compression therapy."

Learn more at http://www.vascularprn.com

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Tampa, FL -- (SBWIRE) -- 03/11/2016 -- A pair of studies published in 2012 show an increased risk of blood clots among lung cancer patients.

A study published in the Journal of Thrombosis and Thrombolysis identified rates of venous thromboembolism (VTE) among lung cancer patients, some of whom were receiving chemotherapy. Both groups had a higher-than-average risk of VTE, and the increase was more pronounced in the chemotherapy patients. The second study, published in the European Journal of Cancer, found an increased risk of deep vein thrombosis (DVT, a type of VTE) among advanced cancer patients, especially lung cancer patients.

Greg Grambor, president of Vascular PRN, a distributor of pneumatic compression therapy equipment for the prevention of blood clots, explained why cancer patients are often at increased risk of DVT.

"It's not necessarily the cancer itself that increases the risk of DVT, but the concurrent factors," Grambor said. "Surgery increases the risk, as does inactivity due to surgery or general fatigue. Chemotherapy has also been shown to increase the incidence of blood clots."

Chemotherapy can reduce the body's production of anti-clotting proteins, as well as damage blood vessels. Some cancers, among them lung cancer, result in the production of mucin, a substance that increases the incidence of clots.

The American Society of Clinical Oncology and the National Comprehensive Cancer Network issue guidelines for the prevention and treatment of blood clots in cancer patients. In addition to commonly prescribed anticoagulants such as aspirin and warfarin, both groups advise the use of mechanical therapy, such as pneumatic compression devices like those offered by Vascular PRN.

"The incidence of side effects in the use of compression therapy is much lower than in blood-thinning drugs," Grambor said. "We are seeing an increased use of compression therapy in recent years, especially among nursing home residents and post-surgical patients."

Go to http://www.vascularprn.com/

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm